×
0.0179843909060061 0.0179843909060061 0.00101798439090604 0.0176450627757042 0.0234136409908382 0.0373260943332203 0.0688836104513064 0.0770274855785546
Stockreport

BRIEF-Albireo Pharma Says Elobixibat Approved In Japan For Treatment Of Chronic Constipation [Reuters]

ALBIREO PHARMA (ALBO)  More Company Research Source: Reuters
Last albireo pharma earnings: 5/10 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.albireopharma.com/investor-relations
PDF BRIEF-Albireo Pharma Says Elobixibat Approved In Japan For Treatment Of Chronic Constipation | Reuters Reuters Staff 1 Min Read Jan 19 (Reuters) - Albireo Pharma Inc: * ALBIREO TO RECEIVE MORE THAN $55 MILLION(1) IN NONDILUTIVE CASH PAYMENTS * ALBIREO PHARMA INC - ELOBIXIBAT APPROVED IN JAPAN FOR TREATMENT OF CHRONIC CONSTIPATION * ALBIREO PHARMA - JAPAN‘S MINISTRY OF HEALTH, LABOR & WELFARE APPROVED NEW DRUG APPLICATION FOR ELOBIXIBAT FOR TREATMENT OF CHRONIC CONSTIPATION IN JAPAN * ALBIREO PHARMA INC - APPROVAL OF ELOBIXIBAT IN JAPAN TRIGGERS PAYMENTS TO ALBIREO SUBSIDIARY ELOBIX AB FROM EA PHARMA CO LTD * ALBIREO PHARMA - CO ?EXPECTS TO INITIATE A PLANNED PHASE 3 STUDY OF A4250 BY SPRING OF 2018? Source text for Eikon: Further company coverage: All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays. © 2018 Reuters. All Rights Reserved. BRIEF-Albireo Pharma Says Elobixibat Approved In Japan For Treatment Of Chronic Constipation Jan [Read more]

IMPACT SNAPSHOT EVENT TIME: ALBO
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
ALBO alerts
from News Quantified